NasdaqGS:NVAXBiotechs
Is Novavax (NVAX) Being Pulled Between R&D Ambitions and Activist Demands for Discipline?
Novavax recently named Dr. Robert Walker as Executive Vice President and Head of R&D, while activist investor Shah Capital renewed its campaign to oppose board nominees, executive pay, and the current leadership’s approach to partnerships and costs.
These moves highlight a growing tension between an R&D-focused leadership reshuffle and an activist push for a leaner organization and potentially different corporate direction.
Against this backdrop of sharper activist pressure on Novavax’s...